1
|
Grammatico-Guillon L, Laurent E, Fuhrman J, Gaborit C, Vallée M, Dinh A, Sotto A, Bruyere F. Factors associated with urinary diversion and fatality of hospitalised acute pyelonephritis patients in France: a national cross-sectional study (FUrTIHF-2). Epidemiol Infect 2023; 151:e161. [PMID: 37721009 PMCID: PMC10600899 DOI: 10.1017/s0950268823001504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2023] [Revised: 09/04/2023] [Accepted: 09/05/2023] [Indexed: 09/19/2023] Open
Abstract
Acute pyelonephritis (AP) epidemiology has been sparsely described. This study aimed to describe the evolution of AP patients hospitalised in France and identify the factors associated with urinary diversion and fatality, in a cross-sectional study over the 2014-2019 period. Adult patients hospitalised for AP were selected by algorithms of ICD-10 codes (PPV 90.1%) and urinary diversion procedure codes (PPV 100%). 527,671 AP patients were included (76.5% female: mean age 66.1, 48.0% Escherichia coli), with 5.9% of hospital deaths. In 2019, the AP incidence was 19.2/10,000, slightly increasing over the period (17.3/10,000 in 2014). 69,313 urinary diversions (13.1%) were performed (fatality rate 6.7%), mainly in males, increasing over the period (11.7% to 14.9%). Urolithiasis (OR [95% CI] =33.1 [32.3-34.0]), sepsis (1.73 [1.69-1.77]) and a Charlson index ≥3 (1.32 [1.29-1.35]) were significantly associated with urinary diversion, whereas E. coli (0.75 [0.74-0.77]) was less likely associated. The same factors were significantly associated with fatality, plus old age and cancer (2.38 [2.32-2.45]). This nationwide study showed an increase in urolithiasis and identified, for the first time, factors associated with urinary diversion in AP along with death risk factors, which may aid urologists in clinical decision-making.
Collapse
Affiliation(s)
- Leslie Grammatico-Guillon
- Public Health and Prevention Department, Unit of Regional Clinical Epidemiology, Teaching Hospital of Tours, Medical School, University of Tours, Tours, France
| | - Emeline Laurent
- Public Health and Prevention Center, Unit of Regional Clinical Epidemiology, Teaching Hospital of Tours, Research Team “Education, Ethics and Health”, University of Tours, Tours, France
| | - Joseph Fuhrman
- Public Health and Prevention Department, Unit of Regional Clinical Epidemiology, Teaching Hospital of Tours, Medical School, University of Tours, Tours, France
| | - Christophe Gaborit
- Public Health and Prevention Department, Unit of Regional Clinical Epidemiology, Teaching Hospital of Tours, Tours, France
| | - Maxime Vallée
- Service of Urology, Teaching Hospital of Poitiers, Medical School, University of Poitiers, Poitiers, France
| | - Aurélien Dinh
- Service of Infectious Diseases, AP-HP, Medical School, University of Paris, Paris, France
| | - Albert Sotto
- Service of Infectious Diseases, Teaching Hospital of Nimes, Medical School, University of Nimes, Nimes, France
| | - Franck Bruyere
- Service of Urology, Teaching Hospital of Tours, Medical School, University of Tours, Tours, France
| |
Collapse
|
2
|
Gasteratos K, McCarthy M, Chatziathanasiou D, Vradeli G, Vlachopoulos N, Voitsidis P, Goverman J. A Systematic Review of Pediatric Nonaccidental Burns: Protecting the Children Through Knowledge, Vigilance, and Prevention. Ann Plast Surg 2023; 90:551-558. [PMID: 37157138 DOI: 10.1097/sap.0000000000003559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/10/2023]
Abstract
BACKGROUND Inflicted burns on children are a particularly difficult medical and psychosocial issue. Pediatric nonaccidental burns (PNABs) are unfortunately relatively common. In our study, we aim to present the key findings on PNABs with the intention of raising awareness, improving early, and recognizing accurately by identifying red flags, developing triage tools, and establishing prevention strategies for this sensitive issue. METHODS A computerized literature search was conducted on PubMed, Google Scholar, and Cochrane for articles published until November 2020. The online screening process was performed by 3 independent reviewers with the Covidence tool against set inclusion/exclusion criteria. The protocol was reported using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) protocol. The study was registered with the International Prospective Register of Systematic Reviews (PROSPERO). RESULTS A total of 12 studies were included for analysis. Scald burns via forced immersion accounted for the majority of reported PNABs affecting both feet and hands. Complications included wound infection, sepsis, requiring systemic antibiotics, or intensive care. Abused children's parents had a history of mental illness, unemployment, substance abuse, incarceration, and/or low annual income. CONCLUSIONS Scalds via forced immersion remain the most common mechanism of PNABs. All health care professionals must remain vigilant, be able to recognize subtle signs of abuse, triage patients appropriately, report to police and/or social services, and ensure no further harm is made to the child or children. Repeated abuse with burns can lead to death. Prevention and education are the cornerstones for addressing this social phenomenon.
Collapse
Affiliation(s)
| | | | | | - Georgia Vradeli
- Department of Dermatology, Städtisches Klinikum Dessau, Germany
| | | | - Pantelis Voitsidis
- 1st Psychiatric Clinic, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Jeremy Goverman
- Sumner M. Redstone Burn Center, Department of Surgery, Massachusetts General Hospital, Boston, MA
| |
Collapse
|
3
|
A computerized indicator for surgical site infection (SSI) assessment after total hip or total knee replacement: The French ISO-ORTHO indicator. Infect Control Hosp Epidemiol 2021; 43:1171-1178. [PMID: 34496983 DOI: 10.1017/ice.2021.371] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
OBJECTIVE The French National Authority for Health (HAS), with a multidisciplinary working group, developed an indicator 'ISO-ORTHO' to assess surgical site infections (SSIs) after total hip arthroplasty or total knee arthroplasty (THA/TKA) based on the hospital discharge database. We present the ISO-ORTHO indicator designed for SSI automated detection and its relevance for quality improvement and hospital benchmarks. METHODS The algorithm is based on a combination of International Statistical Classification of Diseases, Tenth Revision (ICD-10) and procedure codes of the hospital stay. The target population was selected among adult patients who had a THA or TKA between January 1, 2017, and September 30, 2017. Patients at very high risk of SSI and/or with SSI not related to hospital care were excluded. We searched databases for SSIs up to 3 months after THA/TKA. The standardized infection ratio (SIR) of observed versus expected SSIs was calculated (logistic regression) and displayed as funnel plot with 2 and 3 standard deviations (SD) after adjustment for 13 factors known to increase SSI risk. RESULTS In total, 790 hospitals and 139,926 THA/TKA stays were assessed; 1,253 SSI were detected in the 473 included hospitals (incidence, 0.9%: 1.0% for THA, 0.80% for TKA). The SSI rate was significantly higher in males (1.2%), in patients with previous osteo-articular infection (4.4%), and those with cancer (2.3%), obesity, or diabetes. Most hospitals (89.9%) were within 2 SD; however, 12 hospitals were classified as outliers at more than +3 SD (1.6% of facilities), and 59 hospitals (7.9%) were outliers between +2 SD and +3 SD. CONCLUSION ISO-ORTHO is a relevant indicator for automated surveillance; it can provide hospitals a metric for SSI assessment that may contribute to improving patient outcomes.
Collapse
|
4
|
de Lafforest S, Magnier A, Vallée M, Bey E, Le Goux C, Saint F, Therby A, Zahar JR, Sotto A, Bruyere F, Grammatico-Guillon L. FUrTIHF: French urinary tract infections in healthcare facilities - five-year historic cohort (2014-2018). J Hosp Infect 2021; 116:29-36. [PMID: 34166732 DOI: 10.1016/j.jhin.2021.04.035] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2021] [Revised: 04/19/2021] [Accepted: 04/19/2021] [Indexed: 11/29/2022]
Abstract
BACKGROUND Urinary tract infections (UTIs) are common and diverse. Even when not severe, UTIs regularly lead to hospitalization, but their hospital burden remains unknown. This study aimed to estimate the national incidence of hospitalized UTIs in France. METHODS A historic five-year cohort of adult patients hospitalized with UTIs in France was extracted from the medico-administrative databases using an ICD-10 code algorithm built by a multidisciplinary team. The performance parameters were estimated blindly, by reviewing 1122 cases, using medical reports as the gold standard, giving a global predictive positive value of 70.4% (95% confidence interval 66.6-74.1). The national incidence of UTIs was then estimated. RESULTS A total of 2,083,973 patients with UTIs were hospitalized over the period, giving an adjusted incidence rate of ∼900 cases/100,000 inhabitants, stable over the period, higher in females and increasing with age; 1.2% were device-associated UTIs. Unspecific acute cystitis represented almost two-thirds of cases (63.5%); followed by pyelonephritis (23.6%) and prostatitis (12.4%). More than three-quarters of patients had at least one comorbid condition (76.8%). CONCLUSIONS This national cohort study is the first to date to estimate the incidence of UTI-related hospitalizations in France. UTIs represent a substantial burden of care. Further analysis will provide data for more informed goal-of-care discussions targeting each type of UTI, their management and outcomes.
Collapse
Affiliation(s)
- S de Lafforest
- EpiDcliC, unité de santé publique, SIMEES, CHRU de Tours, France; Faculté de médecine, Université de Tours, France; Equipe EA 7505 Education éthique santé, Université de Tours, France
| | - A Magnier
- CHU d'Angers, service d'urologie, Université Angers, France; Service d'urologie, CHRU de Tours, France
| | - M Vallée
- Department of Urology, Poitiers University Hospital, Université de Poitiers INSERM U1070, "Pharmacologie des Anti-Infectieux", Poitiers, France; CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France
| | - E Bey
- CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France; Urology and Andrology department, University Hospital of Nîmes, Nîmes, France
| | - C Le Goux
- CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France; Urologie Hôpital Privé Nord Parisien, Tassigy, Sarcelles, France
| | - F Saint
- CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France; Department of Urology and Transplantation, CHU Amiens-Picardie. EPROAD Laboratory EA 4669, Picardie Jules Verne University, France
| | - A Therby
- CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France; CH Versailles, France
| | - J R Zahar
- CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France; Infection Control Unit, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Bobigny, France; University Sorbonne Paris Nord, Bobigny, France
| | - A Sotto
- CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France; Service de maladies infectieuses et tropicales, CHU de Nimes, Université de Nimes, France
| | - F Bruyere
- Faculté de médecine, Université de Tours, France; Service d'urologie, CHRU de Tours, France; CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France
| | - L Grammatico-Guillon
- EpiDcliC, unité de santé publique, SIMEES, CHRU de Tours, France; Faculté de médecine, Université de Tours, France; CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France.
| |
Collapse
|